List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 2347 studies with search of:   "Lymphoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults
Conditions: Burkitt's Lymphoma;   Burkitt's Leukemia;   Mediastinal Neoplasms;   Lymphoblastic Lymphoma;   Large Cell Anaplastic Lymphoma
Interventions: Drug: Adriamycin;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone/Prednisolone;   Drug: VP16;   Drug: Ifosfamide;   Drug: Methotrexate;   Drug: G-CSF;   Drug: Rituximab;   Drug: Vincristine/Vindesine;   Procedure: Irradiation (in specific conditions)
2 Completed Combination Chemotherapy and Monoclonal Antibody Therapy Followed by Vaccine Therapy in Treating Patients With Mantle Cell Lymphoma
Conditions: Noncontiguous Stage II Mantle Cell Lymphoma;   Stage IV Mantle Cell Lymphoma;   Contiguous Stage II Mantle Cell Lymphoma;   Stage I Mantle Cell Lymphoma;   Stage III Mantle Cell Lymphoma
Interventions: Drug: autologous tumor cell vaccine;   Drug: cyclophosphamide;   Drug: doxorubicin;   Drug: etoposide;   Drug: filgrastim;   Drug: keyhole limpet hemocyanin;   Drug: prednisone;   Drug: rituximab;   Drug: sargramostim;   Drug: vincristine
3 Recruiting Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat
Conditions: Hodgkin's Lymphoma;   Low Grade Lymphoma;   Lymphoma;   Mantle Cell Lymphoma;   Non-Hodgkin's Lymphoma;   Diffuse Large Cell Lymphoma
Interventions: Drug: AMG 655;   Other: Vorinostat;   Other: Bortezomib
4 Recruiting Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions: Follicular Lymphoma;   Marginal Zone B-Cell Lymphoma;   MALT Lymphoma;   Lymphoma of Mucosa-Associated Lymphoid Tissue;   Lymphoma, Small Lymphocytic;   Waldenstrom Macroglobulinemia;   Mantle-Cell Lymphoma
Intervention: Drug: lenalidomide-low dose dexamethasone plus rituximab
5 Recruiting Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
Conditions: Peripheral T Cell Lymphoma, Unspecified;   Angioimmunoblastic Lymphadenopathy;   AIL Type Lymphoma;   Anaplastic Large Cell Lymphoma, ALK Negative;   Extranodal NK/T-Cell Lymphoma
Interventions: Biological: alemtuzumab;   Drug: chemotherapy
6 Recruiting First-Line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.
Conditions: Follicular Lymphoma;   Marginal Zone Lymphoma;   Small Lymphocytic Lymphoma;   Lymphoplasmacytic Lymphoma
Interventions: Drug: Rituximab, Cyclophosphamide, Vincristine, Prednisone;   Drug: Rituximab, Cyclophosphamid, Doxorubicin, Vincristine, Prednisone
7 Withdrawn Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
Conditions: AIDS-Related Lymphoma;   Adult Non-Hodgkin's Lymphoma;   Anaplastic Large Cell Lymphoma
Interventions: Drug: cisplatin;   Drug: cytarabine;   Drug: etoposide;   Drug: methylprednisolone;   Drug: rituximab;   Drug: yttrium Y 90 ibritumomab tiuxetan;   Procedure: antibody therapy;   Procedure: biological therapy;   Procedure: chemotherapy;   Procedure: monoclonal antibody therapy;   Procedure: radiation therapy;   Procedure: radioimmunotherapy;   Procedure: radioisotope therapy
8 Recruiting Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas
Conditions: Peripheral T-Cell Lymphomas;   Adult T-Cell Leukemia;   Adult T-Cell Lymphoma;   Peripheral T-Cell Lymphoma Unspecified;   Angioimmunoblastic T-Cell Lymphoma;   Anaplastic Large Cell Lymphoma;   T/Null Cell Systemic Type;   Cutaneous t-Cell Lymphoma With Nodal/Visceral Disease
Intervention: Drug: Lenalidomide
9 Active, not recruiting Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Conditions: Burkitt Lymphoma;   Non-Hodgkins Lymphoma;   Atypical Burkitt Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Leucovorin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Mesna
10 Completed Phase II Safety and Efficacy Study of Single-Agent AT-101 in Patients With Relapsed or Refractory B-Cell Malignancies
Conditions: Follicular Lymphoma;   Diffuse Large Cell Lymphoma;   Mantle Cell Lymphoma;   Small Lymphocytic Lymphoma;   Chronic Lymphocytic Leukemia
Intervention: Drug: AT-101
11 Withdrawn Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
Conditions: Contiguous Stage II Mantle Cell Lymphoma;   Noncontiguous Stage II Mantle Cell Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage IV Mantle Cell Lymphoma;   Recurrent Mantle Cell Lymphoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1;   Procedure: alternative product therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy
12 Recruiting A Phase I Clinical Trial to Assess the Safety of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Diffuse Large B-Cell Lymphoma;   Mantle Cell Lymphoma;   Follicular Lymphoma
Interventions: Drug: SyB L-0501;   Drug: Rituximab
13 Completed VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma
Conditions: B-Cell Lymphoma;   Follicular Lymphoma;   Marginal Lymphoma
Intervention: Drug: VELCADE and rituximab
14 Recruiting Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphomas
Conditions: Non-Hodgkin's Lymphoma;   Follicular Lymphoma;   Marginal Zone Lymphoma;   Mantle Cell Lymphoma;   Small Lymphocytic Lymphoma;   Lymphoplasmacytic Lymphoma;   Diffuse Large B-Cell Lymphoma;   T-Cell Lymphomas
Intervention: Drug: Clofarabine
15 Recruiting A Study of the Monoclonal Antibody CT-011 in Diffuse Large B-Cell Lymphoma Following Autologous Stem Cell Transplantation
Conditions: Lymphoma, Large Cell, Diffuse;   Lymphoma, Mixed Cell, Diffuse;   Primary Mediastinal Large B-Cell Lymphoma;   Transformed Follicular Lymphoma;   Relapsed
Intervention: Drug: CT-011
16 Recruiting A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Follicular Lymphoma;   Diffuse Large Cell Lymphoma
Intervention: Drug: Iodine I 131 Tositumomab Therapeutic Regimen
17 Active, not recruiting Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
Conditions: B Cell Lymphoma;   Follicular Lymphoma;   Lymphoma
Interventions: Drug: Id-KLH Vaccine;   Drug: GM-CSF
18 Completed Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Low-Grade;   Lymphoma, Small Lymphocytic;   Lymphoma, Mixed-Cell, Follicular;   Lymphoma, Small Cleaved-Cell, Follicular
Interventions: Drug: Pixantrone (BBR 2778);   Drug: fludarabine;   Drug: dexamethasone;   Drug: rituximab
19 Terminated Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Follicular;   Lymphoma, Mixed-Cell, Follicular;   Lymphoma, Small Cleaved-Cell, Follicular;   Lymphoma, Low-Grade
Interventions: Drug: rituximab;   Drug: Pixantrone (BBR 2778)
20 Completed Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
Conditions: Burkitt Lymphoma;   Lymphoma, Large-Cell, Diffuse;   Lymphoma, Small Noncleaved-Cell
Intervention: Drug: granulocyte-macrophage colony stimulating factor (GM-CSF)

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services